Adicet Bio, Inc. - stock earnings
ACET Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -49.9 million USD | ? USD |
| 2023Q2 | -32.4 million USD | ? USD |
| 2023Q1 | -29.6 million USD | ? USD |
| 2022Q4 | -28.1 million USD | -25.0 million USD |
| 2022Q3 | -21.0 million USD | ? USD |
| 2022Q2 | -22.4 million USD | ? USD |
| 2022Q1 | 4.6 million USD | 25.0 million USD |
| 2021Q4 | -15.8 million USD | 5.5 million USD |
| 2021Q3 | -14.0 million USD | 3.4 million USD |
| 2021Q2 | -10.9 million USD | 4.8 million USD |
| 2021Q1 | -21.3 million USD | -4.0 million USD |
| 2020Q4 | -9.0 million USD | 5.4 million USD |
| 2020Q3 | -14.8 million USD | 3.0 million USD |
| 2020Q2 | -8.5 million USD | 7.5 million USD |
| 2020Q1 | -4.5 million USD | 2.0 million USD |
| 2019Q4 | -6.6 million USD | 2.0 million USD |
| 2019Q3 | -14.8 million USD | -7.0 million USD |
| 2019Q2 | -18.3 million USD | 163.6 million USD |
| 2019Q1 | -11.1 million USD | ? USD |
| 2018Q4 | -68.0 million USD | -430.5 million USD |
| 2018Q3 | -8.4 million USD | 164.4 million USD |
| 2018Q2 | -13.6 million USD | 95.8 million USD |
| 2018Q1 | -9.9 million USD | 186.0 million USD |
| 2017Q4 | -64.2 million USD | -430.5 million USD |
| 2017Q3 | 454000 USD | 185.3 million USD |
| 2017Q2 | 25.4 million USD | 114.8 million USD |
| 2017Q1 | 5.6 million USD | 190.1 million USD |
| 2016Q4 | -564000 USD | 125.6 million USD |
| 2016Q3 | 4.4 million USD | 128.0 million USD |
| 2016Q2 | 5.5 million USD | 123.9 million USD |
| 2016Q1 | 10.4 million USD | 157.9 million USD |
| 2015Q4 | 8.3 million USD | 131.7 million USD |
| 2015Q3 | 9.3 million USD | 133.5 million USD |
| 2015Q2 | 9.2 million USD | 109.8 million USD |
| 2015Q1 | 8.4 million USD | 145.8 million USD |
| 2014Q4 | 6.6 million USD | 123.8 million USD |
| 2014Q3 | 4.8 million USD | 130.8 million USD |
| 2014Q2 | 5.6 million USD | 129.1 million USD |
| 2014Q1 | 5.4 million USD | 124.8 million USD |
| 2013Q4 | 6.8 million USD | 116.5 million USD |
| 2013Q3 | 11.3 million USD | 129.3 million USD |
| 2013Q2 | 5.4 million USD | 123.1 million USD |
| 2013Q1 | 7.6 million USD | 150.9 million USD |
| 2012Q4 | 4.5 million USD | 114.0 million USD |
| 2012Q3 | 4.8 million USD | 111.7 million USD |
| 2012Q2 | 4.0 million USD | 110.9 million USD |
| 2012Q1 | 5.4 million USD | 121.4 million USD |
| 2011Q4 | 4.6 million USD | 110.7 million USD |
| 2011Q3 | 3.0 million USD | 101.3 million USD |
| 2011Q2 | 3.5 million USD | 121.2 million USD |
| 2011Q1 | 3.8 million USD | 117.9 million USD |
| 2010Q4 | -1.2 million USD | 85.7 million USD |
| 2010Q3 | 2.8 million USD | 87.7 million USD |
| 2010Q2 | 4.2 million USD | 105.8 million USD |
| 2010Q1 | 3.8 million USD | 99.3 million USD |
| 2009Q4 | -2.5 million USD | 70.9 million USD |
| 2009Q3 | 1.0 million USD | 70.6 million USD |
| 2009Q2 | 1.1 million USD | 74.8 million USD |
| 2009Q1 | 1.9 million USD | 79.8 million USD |
| 2008Q4 | 1.1 million USD | 74.2 million USD |
| 2008Q3 | 4.6 million USD | 93.8 million USD |
| 2008Q2 | 8.0 million USD | 104.7 million USD |
| 2008Q1 | 3.3 million USD | 98.3 million USD |
| 2007Q4 | 908000 USD | 77.1 million USD |
| 2007Q3 | 1.3 million USD | 79.5 million USD |
| 2007Q2 | 4.2 million USD | 87.2 million USD |
| 2007Q1 | 1.8 million USD | 75.9 million USD |
| 2006Q4 | 1.7 million USD | 75.7 million USD |
| 2006Q3 | 2.5 million USD | 74.7 million USD |
| 2006Q2 | 3.0 million USD | 71.9 million USD |
| 2006Q1 | 2.8 million USD | 80.9 million USD |
| 2005Q4 | 1.5 million USD | 69.6 million USD |
| 2005Q3 | 2.0 million USD | 75.0 million USD |
| 2005Q2 | 2.8 million USD | 73.7 million USD |
| 2005Q1 | 1.9 million USD | 82.5 million USD |
| 2004Q4 | 2.0 million USD | 76.7 million USD |
| 2004Q3 | 3.4 million USD | 80.4 million USD |
| 2004Q2 | 3.3 million USD | 76.1 million USD |
| 2004Q1 | 3.7 million USD | 81.3 million USD |
| 2003Q4 | 3.0 million USD | 68.0 million USD |
| 2003Q3 | 3.1 million USD | 70.9 million USD |
| 2003Q2 | 2.4 million USD | 68.1 million USD |
| 2003Q1 | 2.4 million USD | 70.6 million USD |
| 2002Q4 | 2.3 million USD | 64.6 million USD |
| 2002Q3 | 450000 USD | 68.0 million USD |
| 2002Q2 | 1.6 million USD | 64.7 million USD |
| 2002Q1 | 1.5 million USD | 61.6 million USD |
| 2001Q4 | 1.2 million USD | 55.4 million USD |
| 2001Q3 | 535000 USD | 47.6 million USD |
| 2001Q2 | 222000 USD | 56.0 million USD |
| 2001Q1 | 2.0 million USD | 43.3 million USD |
| 2000Q4 | 1.1 million USD | 37.7 million USD |
| 2000Q3 | 929000 USD | 41.1 million USD |
| 2000Q2 | 1.7 million USD | 43.2 million USD |
| 2000Q1 | 2.1 million USD | 55.5 million USD |
ACET Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -67.0 million USD | 25.0 million USD |
| 2021 | -62.0 million USD | 9.7 million USD |
| 2020 | -36.7 million USD | 17.9 million USD |
| 2019 | -28.1 million USD | 995000 USD |
| 2018 | -9.3 million USD | 8.2 million USD |
| 2017 | 34.8 million USD | 558.5 million USD |
| 2016 | 33.5 million USD | 547.0 million USD |
| 2015 | 29.0 million USD | 510.2 million USD |
| 2014 | 22.3 million USD | 499.7 million USD |
| 2013 | 22.3 million USD | 499.7 million USD |
| 2012 | 17.0 million USD | 444.4 million USD |
| 2011 | 9.0 million USD | 412.4 million USD |
| 2010 | 6.6 million USD | 346.6 million USD |
| 2009 | 8.6 million USD | 322.6 million USD |
| 2008 | 13.5 million USD | 359.6 million USD |
ACET
Price: $1.45
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.31 USD
P/E Ratio: -0.87
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 400300
Ebitda: 12.8 millionMarket Capitalization: 119.1 million
Average Dividend Frequency: 2